biomarkerstrategies.com biomarkerstrategies.com

BIOMARKERSTRATEGIES.COM

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

http://www.biomarkerstrategies.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR BIOMARKERSTRATEGIES.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Thursday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.4 out of 5 with 8 reviews
5 star
6
4 star
1
3 star
0
2 star
0
1 star
1

Hey there! Start your review of biomarkerstrategies.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1 seconds

FAVICON PREVIEW

  • biomarkerstrategies.com

    16x16

  • biomarkerstrategies.com

    32x32

  • biomarkerstrategies.com

    64x64

  • biomarkerstrategies.com

    128x128

CONTACTS AT BIOMARKERSTRATEGIES.COM

PERFECT PRIVACY, LLC

12808 Gra●●●●●●●●●kway West

Jack●●●●ille , FL, 32258

US

1.57●●●●8780
tj●●●●●●●●●@networksolutionsprivateregistration.com

View this contact

PERFECT PRIVACY, LLC

12808 Gra●●●●●●●●●kway West

Jack●●●●ille , FL, 32258

US

1.57●●●●8780
tj●●●●●●●●●@networksolutionsprivateregistration.com

View this contact

PERFECT PRIVACY, LLC

12808 Gra●●●●●●●●●kway West

Jack●●●●ille , FL, 32258

US

1.57●●●●8780
tj●●●●●●●●●@networksolutionsprivateregistration.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2006 April 18
UPDATED
2006 October 17
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 19

    YEARS

  • 6

    MONTHS

  • 17

    DAYS

NAME SERVERS

1
ns79.worldnic.com
2
ns80.worldnic.com

REGISTRAR

NETWORK SOLUTIONS, LLC.

NETWORK SOLUTIONS, LLC.

WHOIS : whois.networksolutions.com

REFERRED : http://networksolutions.com

CONTENT

SCORE

6.2

PAGE TITLE
BioMarker Strategies Homepage | biomarkerstrategies.com Reviews
<META>
DESCRIPTION
BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.
<META>
KEYWORDS
1 snappath
2 ex vivo
3 our pathmap
4 biomarker strategies
5 info@biomarkerstrategies com
6 recent headlines
7 2017 biomarker strategies
8 coupons
9 reviews
10 scam
CONTENT
Page content here
KEYWORDS ON
PAGE
snappath,ex vivo,our pathmap,biomarker strategies,info@biomarkerstrategies com,recent headlines,2017 biomarker strategies
SERVER
Microsoft-IIS/8.5
POWERED BY
ASP.NET
CONTENT-TYPE
iso-8859-1
GOOGLE PREVIEW

BioMarker Strategies Homepage | biomarkerstrategies.com Reviews

https://biomarkerstrategies.com

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

INTERNAL PAGES

biomarkerstrategies.com biomarkerstrategies.com
1

Media Center @ BioMarker Strategies

http://www.biomarkerstrategies.com/media.html

Media Center and Key Milestones. June 29, 2016. BioMarker Strategies Awarded Phase I/II Fast Track National Cancer Institute Grant to Develop Companion Diagnostic Test to Select Optimal Therapy for Patients with Non-Small Cell Lung Cancer. Press Release. June 9, 2016. Presentation by BioMarker Strategies President and CEO Jerry Parrott to BIO 2016 International Convention, June 9, 2016, San Francisco. Video. January 7, 2016 -. August 31, 2015 -. March 24, 2014 -. February 11, 2014 -. January 13, 2014 -.

2

Leadership @ BioMarker Strategies

http://www.biomarkerstrategies.com/leadership.html

Greg Bertenshaw, PhD. Vice President, Research and Development. Chairman and Director;. Co-Founder and Former Chairman and CEO, Dianon Systems. Glenn Miller, PhD. Chair of the Scientific Advisory Board and Director; Former Chief Technology Officer and Executive Vice President, MolecularMD. Chairman and Director;. Co-Founder and Former Chairman and CEO, Dianon Systems. Director, Co-Founder and Former President; President, SJA Healthcare Strategies. Douglas P. Clark,. Glenn Miller, PhD. Dr Greg Bertenshaw,.

3

BioMarker Strategies Homepage

http://www.biomarkerstrategies.com/index.html

BioMarker Strategies has developed the proprietary and recently patented SnapPath Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. SnapPath is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. Presentation by B...

4

Investors and Strategic Partners @ BioMarker Strategies

http://www.biomarkerstrategies.com/investors.html

BioMarker Strategies is a privately held, Maryland-based limited-liability company located in Rockville, Maryland. To date, the company has been funded by private investors, including the Abell Foundation. BioMarker Strategies has also been awarded approximately $5m in non-dilutive funding from the National Cancer Institute to develop the SnapPath. Platform, including a recent $1.5m Phase II SBIR award to develop a predictive diagnostic test for advanced melanoma patients.

5

SnapPath Platform @ BioMarker Strategies

http://www.biomarkerstrategies.com/system.html

BioMarker Strategies developed the proprietary SnapPath Cancer Diagnostics System*. To guide targeted drug development and treatment selection for patients with solid tumor malignancies. Is the only diagnostics system able to generate purified populations of live solid tumor cells from fresh, unfixed samples in a rapid and standardized manner. SnapPath preserves the molecular integrity of these live cells for. The PathMAP Functional Signaling Profiles enabled by the SnapPath System provide direct informa...

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL PAGES IN THIS WEBSITE

7

LINKS TO THIS WEBSITE

lifesciencessummit.org lifesciencessummit.org

2014 Company Presenters | Life Sciences Summit

http://lifesciencessummit.org/2014-presentations

November 2-3, 2016. 10 on the Park ●. Innovative, Fundable, Early Stage Opportunities. Presentations from early-stage companies with innovative technologies and proven management. Click on the logo below to view the company’s presentation from the 2014 Life Sciences Summit . President and CEO Jerry McLaughlin. Previously NuPathe, Merck and Endo Pharmaceuticals. CEO Joe Blanchard, MBA. Rockville, MD: BioMarker Strategies is a privately held Maryland-based company that has pioneered development of the Snap...

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL LINKS TO THIS WEBSITE

2

OTHER SITES

biomarkersresearch.org biomarkersresearch.org

Official Website of Jawaharlal Nehru Institute of Advanced Studies (JNIAS)

Established by Dr. D. Swaminadhan Research Foundation (DSRF), Hyderabad Recognised by the University Grants Commission (UGC) under section 2(f) and 12 (B) of the UGC Act, 1956 Recognised as an Advanced Research Institute by JNT University Hyderabad (JNTUH) and JNT University Anantapur (JNTUA) Registered under the Indian Trusts Act, 1882- Registration Number: 4794 and Societies Registration Act, 1860- Registration Number S/28158]. UGC and SIRO Recognitions. Advisory Council for Education and Research.

biomarkerstoday.com biomarkerstoday.com

BioMarkers Today – Bridging science with clinical medicine

Bridging science with clinical medicine. Full Frame is a Premium Responsive WordPress Theme. This is promotion headline. You can edit this from Appearance - Customize - Theme Options - Promotion Headline Options. Here you can showcase the x number of Featured Content. You can edit this Headline, Subheadline and Feaured Content from "Appearance - Customize - Featured Content Options". March 15, 2015. March 15, 2015. Remembering a genomics champion, Rep. Louise Slaughter. NIH to host a Reddit Ask Me Anythi...

biomarkerstore.com biomarkerstore.com

Web Page Under Construction

This Site Is Under Construction and Coming Soon. This Domain Is Registered with Network Solutions.

biomarkerstore.net biomarkerstore.net

Web Page Under Construction

This Site Is Under Construction and Coming Soon. This Domain Is Registered with Network Solutions.

biomarkerstrategies.biz biomarkerstrategies.biz

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.com biomarkerstrategies.com

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.info biomarkerstrategies.info

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.net biomarkerstrategies.net

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.org biomarkerstrategies.org

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.us biomarkerstrategies.us

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkersusa-congress.com biomarkersusa-congress.com

Biomarkers & Precision Medicine USA Congress, 3-4 October 2016, San Diego , USA

2nd Annual Biomarkers and Precision Medicine USA Congress. 9-10 October 2017, San Diego, USA. View Free Webinar Programmes. An Example of Delegate Attendance. 2016 Speaker Line Up. Q & A. 2017 Biomarkers USA Sponsors. White Papers & Product Announcements. View Free Webinar Programmes. An Example of Delegate Attendance. 2016 Speaker Line Up. Q & A. 2017 Biomarkers USA Sponsors. White Papers & Product Announcements. 2nd Annual Biomarkers & Precision Medicine USA Congress 2017. October 2017, San Diego, USA.